FDA Approves First Ready-to-Use Stem Cell Therapy for Cats
Gallant achieves major FDA milestone for revolutionary stem cell therapy targeting feline chronic gingivostomatitis, offering hope for cats with no treatment options.
US News
Gallant achieves major FDA milestone for revolutionary stem cell therapy targeting feline chronic gingivostomatitis, offering hope for cats with no treatment options.